More than 48 million people in the U.S. suffer from chronic pain, according to the National Institutes of Health. Recent high-profile news cases of opioid usage such as Rush Limbaugh have placed the issue on the front pages, including a debate over dependency vs. addiction, who is “deserving” and who is “undeserving,” of opioid treatment, and whether pain patients should be subjected to different standards of personal scrutiny than other patients.

The DEA claims drug diversion has reached crisis proportions, justifying increased investigative initiatives that frequently circumvent the Congressional appropriations process. Physicians are being prosecuted and imprisoned, and patients sentenced based on pill counts. As a result, physicians are afraid, and pain is going untreated. A bi-partisan amendment sponsored by Reps. Conyers and Paul, M.D., to defund these initiatives failed this session, but is gaining more support..... is law enforcement discouraging patient access to treatment as a result of prosecution of physicians under the Controlled Substances Act?

This distinguished panel will examine the current state of pain management, law enforcement initiatives, patient experiences, economic impact of untreated pain, funding sources, sentencing guidelines, H.R. 3015 prescription drug database act, and solutions for cooperation between lawmakers, regulators, law enforcement and the medical community.